SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a surge in institutional price targets and bullish analyst sentiment highlights the stock's critical role in the AI memory supercycle. Investors are actively debating the sustainability of the recent volatility, balancing concerns over semiconductor sector rotation against reports of long-term supply tightness and massive ongoing demand for high-bandwidth memory.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is trending as investors aggressively shift capital into AI infrastructure, fueled by persistent memory chip shortages and massive demand from hyperscalers. The community is actively debating the sustainability of this memory supercycle, with many pointing to structural scarcity and long-term partnerships with major AI chipmakers as reasons to remain bullish despite volatility.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a sharp sell-off following its WWDC event as investors react to the company's AI strategy, which heavily utilizes Google's Gemini models. The community is actively debating whether the lack of immediate innovation justifies the stock's current premium valuation or if the sell-off represents a classic 'buy the rumor, sell the news' dip.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is capturing significant investor attention as shares trade near 52-week highs, driven by a powerful structural breakout, strong institutional interest, and management's optimistic revenue guidance for 2026. Community discussion remains focused on the company's successful pivot to profitable scaling, with many bulls highlighting management's insider buying and the stock's transition from a long-term consolidation range into a sustained uptrend.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares is surging as investors pivot to shorting the semiconductor sector, fueled by widespread concerns over an overextended AI bubble, rising bond yields, and ongoing geopolitical tensions in the Middle East. The community is actively debating whether the recent market pullback represents a temporary correction or the start of a deeper structural collapse, with many traders closely monitoring Asian market volatility as a lead indicator for further downside.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is currently trending as investors monitor the commercial rollout of ZEVASKYN, with the community closely tracking patient treatment volume, qualified treatment center (QTC) activations, and the impact of the newly effective permanent J-code on reimbursement. Discussion is heavily focused on the company's ability to scale manufacturing to meet demand, the progress of patient onboarding pipelines, and expectations for management to provide clearer guidance on the path toward sustained profitability during upcoming financial updates.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is trending due to a sustained surge in AI-driven storage demand, with investors and analysts highlighting the company's critical role in the data center infrastructure expansion. The community is actively debating the stock's parabolic price trajectory, comparing its momentum to other key memory sector players while monitoring potential volatility and long-term valuation shifts.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as the community debates its rapid pivot to AI infrastructure, fueled by a newly announced $270 million cloud contract with Together AI and the upcoming finalization of its acquisition of Northern Data's massive GPU and data center assets. Investors are actively discussing the stock's potential for a short squeeze, citing record-high short interest and the strategic backing of Tether as key drivers for a potential valuation re-rating.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

The Direxion Daily South Korea Bull 3X Shares (KORU) is experiencing extreme volatility driven by a massive semiconductor cycle and heavy exposure to tech giants like Samsung and SK Hynix. Investors are actively debating the fund's correlation with the KOSPI index and broader US chip trends, with many focused on how institutional rotation into space-tech and upcoming CPI data will impact the fund's highly leveraged structure.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing heightened community debate as investors weigh its potential for a World Cup-driven handle surge against ongoing frustration with management and persistent range-bound trading. While some bulls highlight the company's expansion into all 50 states via prediction markets and profitability, others remain skeptical, citing repeated resistance levels and a lack of significant share price appreciation compared to broader market gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

4D Molecular Therapeutics (FDMT) delivered earnings and revenue surprises of -4.12% and -19.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

New Treatment Modalities Are Reaching Cancers That Resisted Everything Else

New Treatment Modalities Are Reaching Cancers That Resisted Everything Else New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire VANCOUVER, BC, Feb. 17, 2026 Issued...

$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors

$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors $668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors PR Newswire VANCOUVER, BC, Jan. 30, 2026 Issued on behalf of...

Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates

Stevanato (STVN) delivered earnings and revenue surprises of +14.29% and +5.54%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates

Rigel (RIGL) delivered earnings and revenue surprises of +56.99% and +12.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Beats Revenue Estimates

Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of +46.96% and +21.23%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates

Durect (DRRX) delivered earnings and revenue surprises of +46.15% and +39.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

electroCore (ECOR) delivered earnings and revenue surprises of -9.38% and +0.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates

Amneal (AMRX) delivered earnings and revenue surprises of +38.89% and -0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.

Current Price	$2.93
Prev Close	$3.03
Open	$3.10
Dividend Yield	0.00%
50-Day Moving Average	$4.01
Beta	1.54
Avg. Volume	1.38M
PE Ratio	-2.10

52-Week High	$6.16
52-Week Low	$1.96
Market Capitalization	$345.56M
EPS (Annual)	-$1.40
Price to Book	0.96
Revenue Per Employee	$5,325.30

CATXPerspective Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CATX News